Full Text View
Tabular View
No Study Results Posted
Related Studies
Buprenorphine Disposition and Clinical Effects (BUP)
This study is ongoing, but not recruiting participants.
Study NCT01576575   Information provided by Washington University School of Medicine

First Received on April 10, 2012.   Last Updated on May 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Buprenorphine
Rifampin
grapefruit juice
Ketoconazole
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Analgesics
Analgesics, Opioid
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antifungal Agents
Antitubercular Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
Leprostatic Agents
Molecular Mechanisms of Pharmacological Action
Narcotic Antagonists
Narcotics
Nucleic Acid Synthesis Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Washington University School of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services